SS
KURA icon

Sunbelt Securities’s Kura Oncology KURA Stock Holding History

Sunbelt Securities’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$610 Sell
75
-2
-3% -$17 ﹤0.01% 2230
2025
Q4 		$800 Buy
77
+2
+3% +$21 ﹤0.01% 2122
2025
Q3 		$664 Buy
+75
New +$535 ﹤0.01% 2149

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sunbelt Securities's KURA Position: Q1 2026 in Review

Sunbelt Securities reduced its Kura Oncology (KURA) stake by 2.6% in Q1 2026, selling an estimated $17 and leaving 75 shares worth $610. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

Sunbelt Securities first reported a position in KURA in Q3 2025 and has held it in 3 quarters since. The position peaked at $800 in Q4 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Sunbelt Securities held 75 shares of Kura Oncology worth $610 as of Q1 2026.
  • Sunbelt Securities sold 2 Kura Oncology shares in Q1 2026, an estimated $17.
  • Kura Oncology made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2230 holding.
  • Sunbelt Securities first reported a position in Kura Oncology in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Kura Oncology position peaked at $800 in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.